title: Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis.
abstract: We previously report that peptide-pulsed dendritic cell (DC) vaccination, which targeting two peptides (Fba and Met6) expressed on the cell surface of Candida albicans, can induce high degree of protection against disseminated candidiasis in immunocompetent mice. Passive transfer of immune sera from the peptide immunized mice or peptide-related monoclonal antibodies demonstrated that protection was medicated by peptide-specific antibodies. In this study the efficacy of active and passive immunization against disseminated candidiasis was tested in mice with cyclophosphamide-induced neutropenia. Peptide-DC vaccines were given to mice prior to induction of neutropenia. We show active immunization with either Fba or Met6 peptide-DC vaccine significantly improved the survival and reduced the fungal burden of disseminated candidiasis in those immunocompromised mice. Importantly, we show that administration of two protective monoclonal antibodies also protect neutropenic mice against the disease, implying possibility of developing a successful passive immunotherapy strategy to treat the disease and protect against disseminated candidiasis. The results of this study are crucial as they address the fundamental questions as to whether the synthetic peptide vaccine induced immunity protects the host during a neutropenic episode. We anticipate that this peptide-vaccine study will serve as the foundation of future investigations into new peptide vaccines comprised of cell surface peptides from other medically important Candida species, as well as other fungi.
authors.affiliation: Department of Pediatrics, Louisiana State University Health Sciences Center and Research Institute for Children, Children's Hospital, New Orleans, LA 70118, United States. Electronic address: hxin@chnola-research.org.
authors.forename: Hong
authors.initials: H
authors.lastname: Xin
mesh_terms: D000818:Animals; D000908:Antibodies, Fungal / Q000627:therapeutic use*; D002176:Candida albicans / Q000276:immunology*; D002177:Candidiasis / Q000382:microbiology / Q000517:prevention & control*; D015169:Colony Count, Microbial; D004195:Disease Models, Animal; D005260:Female; D005657:Fungal Vaccines / Q000008:administration & dosage / Q000276:immunology*; D007116:Immunization, Passive / Q000379:methods*; D008807:Mice, Inbred BALB C; D009503:Neutropenia / Q000150:complications*; D016019:Survival Analysis; D016896:Treatment Outcome; D014611:Vaccination / Q000379:methods*; D022223:Vaccines, Subunit / Q000008:administration & dosage / Q000276:immunology
chemical_list: D000908:Antibodies, Fungal; D005657:Fungal Vaccines; D022223:Vaccines, Subunit
keywords: Antibody protection; Candidiasis; Neutropenia; Peptide vaccine